Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by FredTheVoiceon Apr 09, 2018 8:09pm
235 Views
Post# 27856404

Volume and consideration before take-off.....

Volume and consideration before take-off.....
A lot of good news are shared recently on this board since approval. Some were sorry with the low volume pre-approval. When we take a look in the last 10 days, the volume is pretty good and gaining momentum.

The only shadow about TH is  "what will be the market penetration with TROGARZO.....and how fast.....". I dont think we will have a lot of answers before JULY. But speculation will be high.......and we must wisely listen to all clues that tells us that things are moving behind the curtains like we think and wish they are.......and one great clue is INSIDER BUYING. Thanks for sharing.

This stock will (for the folks with a good dose of patience) make us very happy, and before 2019.

A like the confidence on this board, beyond the frustration about the "canadian analysts" and the obsession about a nasdaq listing..........

This stock will fly ........even in Canada. And from the states, you will see.....

FTV.
Bullboard Posts